Primary ALK-Positive Large B Cell Lymphoma of Pancreas

被引：0
作者：
Pritika Kushwaha
Meeta Singh
Anubhav Vindal
Nidhi Verma
Shyama Jain
机构：
[1] Maulana Azad Medical College,Department of Pathology
[2] Maulana Azad Medical College,Department of Surgery
来源：
Journal of Gastrointestinal Cancer | 2022年 / 53卷
关键词：
ALK; Large B cell lymphoma; Pancreas;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：830 / 833
页数：3
相关论文
共 50 条
  • [41] ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients
    Lee, Cheol
    Park, Jeong Whan
    Suh, Ja Hee
    Nam, Kyung Han
    Moon, Kyung Chul
    KOREAN JOURNAL OF PATHOLOGY, 2013, 47 (05) : 452 - 457
  • [42] An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
    Turner, Suzanne D.
    CANCERS, 2017, 9 (10)
  • [43] ALK-Positive NSCLC: A TMH Experience
    Noronha, V.
    Joshi, A.
    Patil, V.
    Goel, A.
    Talreja, V.
    Kapoor, A.
    Kumar, R.
    Janu, A.
    Mahajan, A.
    Prabhash, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1901 - S1901
  • [44] ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements
    Valera, Alexandra
    Colomo, Lluis
    Martinez, Antonio
    de Jong, Daphne
    Balague, Olga
    Matheu, Gabriel
    Martinez, Monica
    Taddesse-Heath, Lekidelu
    Jaffe, Elaine S.
    Bacchi, Carlos E.
    Campo, Elias
    MODERN PATHOLOGY, 2013, 26 (10) : 1329 - 1337
  • [45] Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature
    Grewal, Jaspreet S.
    Smith, Lauren B.
    Winegarden, Jerome D., III
    Krauss, John C.
    Tworek, Joseph A.
    Schnitzer, Bertram
    ANNALS OF HEMATOLOGY, 2007, 86 (07) : 499 - 508
  • [46] Combination ALK and MEK Inhibition in ALK-Positive Lung Cancer
    Ashton, J.
    Shrestha, N.
    Bland, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S857 - S857
  • [47] Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature
    Jaspreet S. Grewal
    Lauren B. Smith
    Jerome D. Winegarden
    John C. Krauss
    Joseph A. Tworek
    Bertram Schnitzer
    Annals of Hematology, 2007, 86 : 499 - 508
  • [48] D2-40 expression in ALK-positive anaplastic large cell lymphoma resembles CD30 expression: a potential diagnostic pitfall
    Liu, Yingjie
    Li, Congyang
    Guo, Changsheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3727 - 3734
  • [49] Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases
    Lin, Jessica J.
    Jiang, Ginger Y.
    Joshipura, Nencyben
    Ackil, Jennifer
    Digumarthy, Subba R.
    Rincon, Sandra P.
    Yeap, Beow Y.
    Gainor, Justin F.
    Shaw, Alice T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : 683 - 690
  • [50] ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis - Report of three cases and review of the literature
    Onciu, M
    Behm, FG
    Raimondi, SC
    Moore, S
    Harwood, EL
    Pui, CH
    Sandlund, JT
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (04) : 617 - 625
12345